Acute heart failure prevention resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{CMG}}; {{AE}} {{MS}}; {{AO}} ==Overview== ==Prevention== {{familytree/start}} {{familytree | | | | | A00 | | A00=<div style="float: left; text-align: left; width..." |
|||
Line 8: | Line 8: | ||
{{familytree | | | | | A00 | | A00=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Does the patient have stage A or stage B of heart failure according to the [[Acute heart failure resident survival guide#Classification|ACCF/AHA staging system]]?'''</div>}} | {{familytree | | | | | A00 | | A00=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Does the patient have stage A or stage B of heart failure according to the [[Acute heart failure resident survival guide#Classification|ACCF/AHA staging system]]?'''</div>}} | ||
{{familytree | |,|-|-|-|+|-|-|-|.| | | | }} | {{familytree | |,|-|-|-|+|-|-|-|.| | | | }} | ||
{{familytree | Z01 | | Z02 | | Z03 | |Z01=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''[[Acute heart failure resident survival guide#Prevention of Heart Failure|Stage A]]''' <br> <br> | |||
❑ '''At high risk for heart failure''' <br> | |||
:❑ Patients with [[HTN]], [[DM]], [[obesity]], [[CAD]], [[metabolic syndrome]]<br> | |||
:❑ Family history of [[cardiomyopathy]]<br> | |||
:❑ Patients using cardiotoxins | |||
<br> '''AND'''<br> | |||
❑ '''No structural heart disease''' | |||
<br> '''AND'''<br> | |||
❑ '''No symptom of heart failure'''<br></div>|Z02=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''[[Acute heart failure resident survival guide#Prevention of Heart Failure|Stage B]]''' <br> <br> | |||
❑ '''Patients with structural heart disease'''<br> | |||
This refers to patients with the following:<br> | |||
:❑ Previous [[MI]]<br> | |||
:❑ LV remodeling* (including [[ LVH]] + low [[EF]])<br> | |||
:❑ Asymptomatic [[valvular disease]]<br><br>'''AND'''<br> | |||
❑ '''No signs or symptoms of heart failure'''<br><br> | |||
''LV remodeling refers to the changes in size, shape and function of the heart resulting from cardiac load or injury''</div>|Z03=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Neither stage A nor stage B'''</div>}} | |||
{{familytree | |!| | | |!| | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | }} | |||
{{familytree | A01 | | A02 | | A03 | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Yes, the patient has stage A''' | {{familytree | A01 | | A02 | | A03 | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Yes, the patient has stage A''' | ||
---- | ---- | ||
Line 17: | Line 36: | ||
Therapeutic goal: | Therapeutic goal: | ||
❑ Prevent symptoms of heart failure</div> | ❑ Prevent symptoms of heart failure</div> | ||
|A03=<div style="float: left; text-align: left; width: 20em; padding:1em;"> | |A03=<div style="float: left; text-align: left; width: 20em; padding:1em;">No preventive therapy is needed</div> | ||
}} | |||
No preventive therapy is needed</div>}} | |||
{{familytree | |!| | | |!| |}} | {{familytree | |!| | | |!| |}} | ||
{{familytree | B01 | | B02 | | |B01=<div style="float: left; text-align: left; width: 20em; padding:1em;"> | {{familytree | B01 | | B02 | | |B01=<div style="float: left; text-align: left; width: 20em; padding:1em;"> |
Revision as of 21:24, 6 May 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahmoud Sakr, M.D. [2]; Ayokunle Olubaniyi, M.B,B.S [3]
Overview
Prevention
Does the patient have stage A or stage B of heart failure according to the ACCF/AHA staging system? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stage A ❑ At high risk for heart failure
| Stage B ❑ Patients with structural heart disease
❑ No signs or symptoms of heart failure | Neither stage A nor stage B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes, the patient has stage A
Therapeutic goals: | Yes, the patient has stage B
Therapeutic goal: ❑ Prevent symptoms of heart failure | No preventive therapy is needed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Control HTN and lipid disorders
❑ Minimize risk factors
| ❑ Administer ACE inhibitors or (ARBs) in patients with:
❑ Administer beta blockers in patients with:
❑ Statins
❑ Implantable cardioverter defibrillator (ICD) to prevent sudden death in:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||